CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD
Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.
Digitally Enabled Care in Focus as NHS selects Ampersand Health for DigitalHealth.London Accelerator
09 Sep 2019
Ampersand Health Featured in Spoonie Magazine
20 May 2021
The article, titled: ‘Do More and Feel Better? Let’s Talk About Pacing.’ gave tips and advice for people living with chronic illnesses like inflammatory...
Ampersand to be included in the #Beyond100
21 Jan 2022
We are honoured for Ampersand to be included in the #Beyond100, published by the Department for International Trade (DIT).
Ampersand Health Selected for PharmStars Accelerator Programme
06 Dec 2023
Ampersand Health, alongside 10 other leading health tech innovations, has successfully graduated from PharmStars.
Ulm University & University of Freiburg Conduct Study on Apps for GI Disorders, Including My IBD Care
20 Oct 2022
They evaluated the general characteristics, content and functions, privacy and security features and overall quality rating of 109 apps for GI disorders found...
